NASDAQ:VRDN News 15 December 2025

Viridian Therapeutics stock jumps to a 52-week high as VRDN traders zero in on June FDA deadline

Viridian Therapeutics shares jumped 6.4% to a 52-week high Wednesday, defying a broader market decline. The move comes as investors await the FDA’s June 30 decision on veligrotug for thyroid eye disease. Viridian was valued near $3.1 billion and reported $888 million in cash as of October.

14 January 2026

Biotechnology·NASDAQ:VRDN·Pharmaceuticals

Viridian Therapeutics, Inc. (VRDN) Stock Surges on Dec. 15, 2025: Latest News, Analyst Forecasts, and 2026 Catalysts

Viridian Therapeutics, Inc. stock (Nasdaq: VRDN) is back in the spotlight on December 15, 2025, as shares push to fresh highs amid a mix of sector news, new Wall Street coverage, and a shifting competitive landscape in thyroid eye disease (TED)—the company’s core focus. As of 9:47 a.m. ET (14:47 UTC), VRDN stock traded at $33.84, up about 4.7% on the day, after touching an intraday high of $34.92. That move extends a strong multi-month run and underscores how quickly sentiment can change around late-stage biotech names when the market smells a cleaner path to commercialization. VRDN stock today: price

15 December 2025

Biotechnology·NASDAQ:VRDN·Stock Market

Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

8 February 2026

Longsys disclosed new guarantees for a 100 million yuan Hong Kong loan and a $9 million Brazil credit line, bringing its total approved guarantee quota to 11 billion yuan and outstanding guarantees to 5.81 billion yuan. The company said all guarantees are for consolidated subsidiaries and within approved limits. Shares closed at 288 yuan Friday, down 1.6%. China inflation and credit data are due this week.

MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

8 February 2026

MACOM shares rose 3.5% to $235.87 Friday after the company reported fiscal Q1 revenue of $271.6 million and raised its full-year data center growth outlook to 35–40%. Fidelity’s FMR LLC disclosed a 10.7% stake, while shareholder Susan Ocampo filed to potentially sell up to 100,000 shares. Stifel raised its price target to $255. MACOM expects to repay $161 million in convertible notes in March.

LONGi Green Energy stock in focus: 1.65 bln yuan patent fee signals higher costs as China solar outlook softens

8 February 2026

LONGi Green Energy’s Shanghai A-shares closed up 0.7% at 18.36 yuan on Friday after a 1.65 billion yuan BC solar patent licensing deal was disclosed this week. The agreement, involving Aiko Solar and Maxeon, set a price for key solar IP as industry forecasts point to a drop in China’s 2026 new solar installations.

Fabrinet stock price jumps nearly 14%: what FN investors watch before Monday’s open

8 February 2026

Fabrinet shares surged 13.8% to $503.99 Friday after a volatile week, boosted by a strong earnings report and analyst upgrades. The company posted quarterly revenue of $1.13 billion and non-GAAP EPS of $3.36, both above guidance. Barclays raised its price target to $548. U.S. jobs and inflation data next week may influence trading.

NASDAQ:VRDN News 15 December 2025 - 14 January 2026

Viridian Therapeutics stock jumps to a 52-week high as VRDN traders zero in on June FDA deadline

Viridian Therapeutics, Inc. (VRDN) Stock Surges on Dec. 15, 2025: Latest News, Analyst Forecasts, and 2026 Catalysts

Stock Market Today

Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

LONGi Green Energy stock in focus: 1.65 bln yuan patent fee signals higher costs as China solar outlook softens

Fabrinet stock price jumps nearly 14%: what FN investors watch before Monday’s open